BFC Planning’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.5K Hold
47
– – ﹤0.01% 2309
2026
Q2
$9.6K Buy
+47
New +$8.84K ﹤0.01% 2387

Other funds holding BBH

BFC Planning's BBH Position: Q3 2026 in Review

BFC Planning held its VanEck Biotech ETF (BBH) position steady in Q3 2026 at 47 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2309.

BFC Planning first reported a position in BBH in Q2 2026 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

  • BFC Planning held 47 shares of VanEck Biotech ETF worth $11.5K as of Q3 2026.
  • BFC Planning left its VanEck Biotech ETF share count unchanged in Q3 2026.
  • VanEck Biotech ETF made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2309 holding.
  • BFC Planning first reported a position in VanEck Biotech ETF in Q2 2026 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.